MOMA Therapeutics logo

MOMA Therapeutics Funding & Investors

MOMA Therapeutics operates as a biotechnology company. MOMA Therapeutics discover the next generation of precision medicines by targeting the molecular machines that underlie human disease.

momatx.com

Total Amount Raised: $236,000,000

MOMA Therapeutics Funding Rounds

  • Series B

    $150,000,000

    Series B Investors

    LifeSci Venture Partners
    Creacion Ventures
    Invus
    Third Rock Ventures
    Cormorant Asset Management
    Nextech Invest
    Section 32
    Pavilion Capital
    Goldman Sachs Asset Management
    Rock Springs Capital
    Casdin Capital
    Alexandria Real Estate Equities
  • Series A

    $86,000,000

    Series A Investors

    Creacion Ventures
    Third Rock Ventures
    Nextech Invest
    Cormorant Asset Management
    Rock Springs Capital
    Casdin Capital
    Alexandria Real Estate Equities
Funding info provided by Diffbot.